semaglutide for research Peptide Semaglutide GLP-1 Receptor Agonist Research

Fras JP, Auerbach P, Bajaj HS, et al

Advertised as supporting up to 25% body weight loss

Hot flashes are not listed as a recognized adverse effect in FDA prescribing information for tirzepatide

Quick Answer: Weight loss injections (GLP-1 receptor agonists) can generally be used safely in patients with well-controlled hypothyroidism, as they don't directly interfere with thyroid hormone production or replacement therapy

Keep in mind that Trulicity can interact with certain diabetes drugs

[1] For constipation-related abdominal pain , increasing dietary fibre gradually, maintaining adequate hydration, and engaging in regular physical activity can be beneficial